| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/22/2012 | CN101785757B 一种紫杉醇自乳化制剂及其制备方法和用途 One of paclitaxel self-emulsifying formulation and preparation method and uses |
| 02/22/2012 | CN101766579B 一种度洛西汀的缓释肠溶制剂及其芯材和制备方法 One kind of duloxetine enteric sustained-release preparation and preparation of the core material and |
| 02/22/2012 | CN101744947B 一种具有增强免疫功能的中草药组合物 Having an enhanced immune function herbal compositions |
| 02/22/2012 | CN101700331B 接骨灵喷雾剂 Bone Spirit sprays |
| 02/22/2012 | CN101669950B 苦豆碱在制备治疗溃疡性结肠炎药物中的应用 Aloperine in the manufacture of a medicament for the treatment of ulcerative colitis |
| 02/22/2012 | CN101668516B 具有改善的维生素d含量均匀度的药物剂型 Vitamin d having improved uniformity of the contents of the pharmaceutical dosage form |
| 02/22/2012 | CN101642510B 一种治疗重症躁狂症的中药组合物及其制备方法 A severe mania Chinese medicine composition and its preparation method of treatment |
| 02/22/2012 | CN101631534B 用于跨膜给药对乙酰氨基酚的盖仑制剂 For transmembrane administration of acetaminophen galenical |
| 02/22/2012 | CN101623322B 一种中药烧、烫伤外用散剂及制备方法 A traditional Chinese medicine burn, burn topical powder and preparation method |
| 02/22/2012 | CN101612217B 一种中药组合物在制备治疗中心性浆液性脉络膜视网膜病变的药物中的应用 A composition for use in the preparation of traditional Chinese medicine treatment of Central serous retinopathy medicament |
| 02/22/2012 | CN101574348B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method |
| 02/22/2012 | CN101505694B 用于递送活性试剂的泪点塞 Punctal plugs for the delivery of active agents |
| 02/22/2012 | CN101480421B 鹰嘴豆油脂在制备治疗糖尿病药物或保健食品的应用 Chickpeas fat in the preparation of the treatment of diabetes drug or health food applications |
| 02/22/2012 | CN101468071B 一种用于抑制和缓解男女性冲动的中药药物 Chinese medicines for containment and mitigation of male and female sexual arousal |
| 02/22/2012 | CN101467987B 碳酸利多卡因注射液的制备方法 Carbonated lidocaine injection preparation |
| 02/22/2012 | CN101396431B 鼻通宁凝胶及其制备方法 Ning gel nose through its preparation method |
| 02/22/2012 | CN101366941B 一种治疗虚寒型肾炎的中药胶囊 A method of treating nephritis medicine capsules Deficiency Type |
| 02/22/2012 | CN101241788B 在生理缓冲液中能够高度溶解并稳定分散的生物相容性磁性纳米晶体及其制备方法 Biocompatible magnetic nanocrystals in a physiological buffer solution can be highly soluble and stable dispersion and its preparation method |
| 02/22/2012 | CN101185733B 一种健胃消食口腔崩解片及制备方法 One kind Jianweixiaoshi orally disintegrating tablets and preparation methods |
| 02/22/2012 | CN101152307B 一种用于治疗腹痛、腹泻的中药软胶囊及其制备方法 A method for the treatment of abdominal pain, diarrhea medicine soft capsule and its preparation method |
| 02/22/2012 | CN101088492B 盐酸吉西他滨稳定的过饱和溶液及其制备方法 Gemcitabine hydrochloride stable supersaturated solution and its preparation method |
| 02/22/2012 | CN101085071B 含有丹参、山楂的中药组合物及其制剂 Containing Salvia, hawthorn herbal compositions and preparations |
| 02/22/2012 | CN101084996B 含有丹参的中药组合物及其制剂 Chinese medicine composition containing Salvia and its preparations |
| 02/22/2012 | CN101040950B 复方鱼腥草滴丸的制备方法 Preparation of Compound Houttuynia dropping pills |
| 02/22/2012 | CN101040935B 一种用于祛痰止咳的滴丸制剂及其制备方法 Dropping Pills and its preparation method for expectorant cough |
| 02/22/2012 | CN101035562B 优选含有如蔗糖醋酸异丁酸酯等糖酯的持续局部麻醉组合物 Preferably such as sugars such as sucrose acetate isobutyrate sustained local anesthesia ester compositions |
| 02/22/2012 | CN101015525B 紫杉醇脂质体及其制备方法 Paclitaxel liposome preparation method thereof |
| 02/22/2012 | CN101002801B 一种增强免疫力的保健食品的制备方法 A method of preparing a health food to enhance immunity |
| 02/21/2012 | US8119611 Treatment of neurodegenerative disease through intracranial delivery of SIRNA |
| 02/21/2012 | US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease |
| 02/21/2012 | US8119604 Polypeptide formulation |
| 02/21/2012 | US8119595 Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119166 Methods of treatment using a gastric retained gabapentin dosage |
| 02/21/2012 | US8119165 Method and composition for hyperthermally treating cells |
| 02/21/2012 | US8119163 Nanoparticulate and controlled release compositions comprising cefditoren |
| 02/21/2012 | US8119162 Particles that disrupt or impede bacterial adhesion, related compositions and methods |
| 02/21/2012 | US8119161 Blister pack and solid dosage form therefor |
| 02/21/2012 | US8119160 Hemostatic compositions and devices |
| 02/21/2012 | US8119159 Bioavailability; absorption; using fatty acid, or salt thereof, or fatty ester |
| 02/21/2012 | US8119158 Effervescent oral fentanyl dosage form and methods of administering fentanyl |
| 02/21/2012 | US8119157 Pharmaceutical compositions for lipophilic drugs |
| 02/21/2012 | US8119156 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 02/21/2012 | US8119154 Sustained release intraocular implants and related methods |
| 02/21/2012 | US8119148 Oxcarbazepine suspension; oral administering |
| 02/21/2012 | US8119127 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 02/21/2012 | US8119113 Coenzyme Q10—containing composition |
| 02/21/2012 | US8119109 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions |
| 02/21/2012 | US8119106 Foamable iodine compositions |
| 02/21/2012 | US8119105 Free of fluorochlorohydrocarbons; fluorohydrocarbon propellant; antiasthmatics |
| 02/21/2012 | US8119102 Pharmaceutical composition of nanoparticles |
| 02/21/2012 | US8119101 Anti-CD74 immunoconjugates and methods of use |
| 02/21/2012 | CA2657911C Pharmaceutical compositions for sustained release delivery of peptides |
| 02/21/2012 | CA2540170C Stabilized formulations of phosphatidylserine |
| 02/21/2012 | CA2540109C Method for stabilization of diarylvinylene compounds |
| 02/21/2012 | CA2524091C Pharmaceutical formulation of the telmisartan sodium salt |
| 02/21/2012 | CA2504610C Fast-disintegrating solid dosage forms being not friable and comprising pullulan |
| 02/21/2012 | CA2472432C Soft tablet containing high molecular weight cellulosics |
| 02/21/2012 | CA2433244C Injectable microdispersions for medical applications |
| 02/21/2012 | CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/21/2012 | CA2386506C Isolation of precursor cells and their use for tissue repair |
| 02/21/2012 | CA2362022C Methods of microencapsulating pancreatic islet cells |
| 02/21/2012 | CA2354045C New cancer treatments |
| 02/21/2012 | CA2351593C Polymer grafting by polysaccharide synthases |
| 02/21/2012 | CA2287800C Compound containing hydroxypropylcellulose, hydroxypropylmethylcellulose, and/or ethylcellulose as disintegrating agents, and production process |
| 02/20/2012 | DE202007019381U1 Manipulationssichere Dosierungsform The tamper-resistant dosage form |
| 02/16/2012 | WO2012021860A1 Compositions and methods for treating cardiovascular disease |
| 02/16/2012 | WO2012021856A1 Compositions and methods for treatment of taupathy |
| 02/16/2012 | WO2012021791A2 Aqueous formulation with improved stability |
| 02/16/2012 | WO2012021790A1 Liposome compositions and methods of use thereof |
| 02/16/2012 | WO2012021735A2 Pharmaceutical products from gungal strains |
| 02/16/2012 | WO2012021512A2 Erythrocyte-binding therapeutics |
| 02/16/2012 | WO2012021432A2 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
| 02/16/2012 | WO2012021108A1 A biodegradable ocular implant |
| 02/16/2012 | WO2012020790A1 Anti-infective agent |
| 02/16/2012 | WO2012020767A1 Pyrroloquinoline quinone gel |
| 02/16/2012 | WO2012020566A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection |
| 02/16/2012 | WO2012020412A2 Fibrin based scaffold, preparation and use thereof |
| 02/16/2012 | WO2012020377A1 Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation |
| 02/16/2012 | WO2012020368A1 Olmesartan formulations |
| 02/16/2012 | WO2012020337A1 Polymerized micelles for diagnosis |
| 02/16/2012 | WO2012020301A2 Oral controlled release pharmaceutical compositions of blonanserin |
| 02/16/2012 | WO2012020279A1 Product for the upper gastric sphere |
| 02/16/2012 | WO2012020261A2 Structures for transdermal drug delivery |
| 02/16/2012 | WO2012020219A2 Formulations for infusion of type b lantibiotics |
| 02/16/2012 | WO2012020097A2 Use of binders for manufacturing storage stable formulations |
| 02/16/2012 | WO2012019990A2 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| 02/16/2012 | WO2012019989A2 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| 02/16/2012 | WO2012019633A1 Pharmaceutical granulate comprising imatinib mesylate |
| 02/16/2012 | WO2012019533A1 Electronic cigarette's atomization composition with calcium pectate gel and preparation process and use thereof |
| 02/16/2012 | WO2012019439A1 Huperzine a ophthalmic microemulsion and preparation method thereof |
| 02/16/2012 | WO2012019288A1 Foamable compositions of stabilized chlorite |
| 02/16/2012 | WO2011152809A3 Effervescent formulations comprising cephalosporin and clavulanic acid |
| 02/16/2012 | WO2011123180A4 Medical devices including medicaments and methods of making and using same |
| 02/16/2012 | WO2011107525A4 Activatable drug dispensing system |
| 02/16/2012 | WO2011023465A3 Antimicrobial ether guanidines |
| 02/16/2012 | WO2002085309A9 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent |
| 02/16/2012 | US20120042398 Compositions for labeling and identifying autophagosomes and methods for making and using them |
| 02/16/2012 | US20120041481 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 02/16/2012 | US20120041415 Medication delivery system and monitor |